News for Akebia Therapeutics Stock (AKBA)

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/19/22

ROSEN, A LEADING AND RANKED FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/17/22

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/16/22

ROSEN, A LEADING AND RANKED FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/14/22

Best Penny Stocks To Buy Now? 5 Stocks Under $1 To Watch In April

PennyStocks • 04/14/22

AKBA INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

PRNewsWire • 04/13/22

AKBA LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/11/22

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/10/22

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/07/22

Akebia Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2022 to Discuss Your Rights - AKBA

Newsfile Corp • 04/06/22

ROSEN, A LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

PRNewsWire • 04/06/22

Akebia Therapeutics Announces Poster Presentations at National Kidney Foundation Spring Clinical Meetings 2022

PRNewsWire • 04/06/22

AKBA INVESTOR NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/05/22

AKEBIA THERAPEUTICS, INC. (NASDAQ: AKBA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Akebia Therapeutics, Inc. (NASDAQ: AKBA)

PRNewsWire • 04/05/22

ROSEN, A TOP RANKED FIRM, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/04/22

AKBA INVESTOR NEWS: ROSEN, LEADING INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/01/22

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 03/31/22

6 Stocks Halted In Wednesday's Session

Benzinga • 03/30/22

FDA Rejects Akebia Therapeutics' Vadadustat For CKD-Associated Anemia

Benzinga • 03/30/22

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

PRNewsWire • 03/30/22

Akebia Therapeutics Receives Complete Response Letter from the FDA for Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients

PRNewsWire • 03/30/22

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 03/29/22

ROSEN, A TOP RANKED LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 03/25/22

AKEBIA THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Akebia Therapeutics, I

PRNewsWire • 03/24/22

ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

PRNewsWire • 03/23/22